WALBAMPRA
Pharmaceutical products for the treatment of neurological diseases and disorders; pharmaceutical products for the treatment of autoimmune diseases and disorders; pharmaceutical products for the treatment of multiple sclerosis (MS); pharmaceutical products for the treatment of walking diseases and disorders
Pending · April 8, 2025 · 99127137 ·